Table 1. Patients characteristics at inclusion.
| Whole study group | Patients with baseline and one-year data | Patients with baseline data only | |
| n | 111 | 71 | 40 |
| Age (yr) | 38.20±7.87 | 37.15±7.98 | 40.06±7.40 |
| Male sex – no. (%) | 62(55.86) | 34(47.89) | 28(70.00) |
| Height (cm) | 171.12±9.50 | 170.01±9.85 | 173.08±8.62 |
| Weight (Kg) | 73.28±14.65 | 72.49±14.58 | 74.68±14.86 |
| Body Mass Index (kg/m2) † | 24.91±3.86 | 24.96±3.91 | 24.81±3.83 |
| Body Surface Area (m2) $ | 1.85±0.21 | 1.83±0.21 | 1.88±0.21 |
| Systolic Blood Pressure (mmHg) | 130.21±15.50 | 127.74±15.49 | 136.06±14.08∧ |
| Diastolic Blood Pressure (mmHg) | 84.91±11.22 | 84.07±12.22 | 86.89±8.25 |
| Serum creatinine (mg/dL) ∫ | 1.21±0.46 | 1.12±0.45 | 1.37±0.46∧ * |
| Uric Acid (mg/dL) | 5.41±1.61 | 5.18±1.63 | 5.83±1.50∧ |
| GOT/AST (U/L) | 19.99±6.36 | 19.61±7.24 | 20.69±4.33 |
| GPT/ALT (U/L) | 20.09±11.07 | 19.48±12.39 | 21.21±8.17 |
| Proteinuria (g/24 h) | 0.25±0.52 | 0.28±0.62 | 0.16±0.13 |
| Albuminuria (µg/min) | 52.86±65.02 | 61.89±79.63 | 40.81±35.36 |
| GFR (mL/min/1.73 m2) | 78.56±26.70 | 83.13±27.52 | 70.45±23.38∧ |
| Antihypertensive therapy - no. (%) | 73 (65.77) | 44 (61.97) | 29 (72.50) |
| ACEi – no. (%) | 55 (49.55) | 33 (46.48) | 23 (57.50) |
| CCB – no. (%) | 12 (10.81) | 8 (11.27) | 4 (10.00) |
| ARBs – no. (%) | 23 (20.72) | 16 (22.54) | 7 (17.50) |
| Antihypertensive drugs - no. | 2 (1–3) | 2 (1–3) | 1 (1–2) |
Data are mean±SD.
†
The body mass index is the weight in kilograms divided by the square of the height in meters.
$
The body surface area is calculated with the Dubois&Dubois formula.
∫
To convert values for serum creatinine to micromoles per liter, multiply by 88.4.
*
p<0.05 vs. whole study group;
∧
p<0.05 vs. patients with baseline and one-year data.